The Australian Medical Research Advisory Board (AMRAB) develops the priorities every 2 years to inform Government decisions on MRFF investments in health and medical research.
AMRAB consulted on the 2020–2022 priorities between 9 September 2020 and 7 October 2020 through our consultation hub and live webinars.
Stakeholders were asked to comment on the appropriateness of the 2018-2020 priorities to guide future MRFF investments under the Australian Medical Research and Innovation Strategy 2016–2021.
AMRAB heard from 270 stakeholders and received more than 250 written submissions.
Read the responses from the public consultation submissions.